title: Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkin's lymphoma?
authors.forename: D
authors.initials: D
authors.lastname: Bernardi
authors.forename: M
authors.initials: M
authors.lastname: Michieli
authors.forename: M
authors.initials: M
authors.lastname: Rupolo
authors.forename: M
authors.initials: M
authors.lastname: Mazzucato
authors.forename: M
authors.initials: M
authors.lastname: Spina
authors.forename: A
authors.initials: A
authors.lastname: Giacalone
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D018570:Risk Assessment; D033581:Stem Cell Transplantation / Q000379:methods*; D016896:Treatment Outcome